Master all 26 flashcards
Explore how GI drugs interact with other medications, absorption issues, and implications for therapy management.
Mastering this deck will enhance your understanding of complex GI drug interactions and pharmacokinetics, enabling more effective and safer therapy management in clinical practice. You'll be equipped to anticipate and mitigate potential drug interactions and absorption challenges, improving patient outcomes.
ℹ️ Educational Use Only: This flashcard deck is created by usersof our platform for their educational and study purposes. The content is not intended as medical advice, diagnosis, or treatment guidance. Always consult qualified healthcare professionals for medical decisions and verify information with authoritative medical sources.
Showing 20 of 26 cardsSample view
| # | Front | Back | Hint |
|---|---|---|---|
| 1 | What is the primary mechanism by which proton pump inhibitors (PPIs) can alter the absorption of other drugs? | PPIs increase gastric pH by inhibiting gastric acid secretion, which can reduce the solubility and absorption of drugs that require an acidic environment, such as certain azole antifungals and calcium salts. | Think of PPIs raising pH, affecting drug solubility. |
| 2 | Name a common medication class whose absorption is significantly decreased when co-administered with antacids containing aluminum or magnesium. | Tetracyclines (e.g., doxycycline) and fluoroquinolones (e.g., ciprofloxacin) experience decreased absorption due to chelation with aluminum or magnesium ions in antacids. | Chelation reduces drug bioavailability. |
| 3 | How can concomitant use of proton pump inhibitors affect the metabolism of drugs that are primarily cleared by CYP2C19? | PPIs are metabolized by CYP2C19 and can inhibit this enzyme, potentially leading to increased plasma levels of drugs metabolized by CYP2C19, such as clopidogrel or diazepam, affecting efficacy and toxicity. | Consider enzyme competition and inhibition. |
| 4 | Why should absorption of iron supplements be monitored when given with proton pump inhibitors? | PPIs raise gastric pH, reducing iron solubility and absorption, which can lead to iron deficiency anemia if not monitored and managed appropriately. | Higher pH, lower iron absorption. |
| 5 | Which gastrointestinal condition is most likely to alter drug absorption due to changes in gastric emptying or mucosal integrity? | Gastroenteritis or inflammatory bowel disease (IBD) can alter absorption by affecting gastric emptying, mucosal surface area, and integrity, leading to unpredictable drug absorption. | Inflammation impacts absorption efficiency. |
| 6 | Describe how enterohepatic recirculation impacts the pharmacokinetics of certain GI drugs. | Enterohepatic recirculation involves the drug being excreted into bile, reabsorbed in the intestine, and returned to systemic circulation, prolonging drug half-life and effects, as seen with drugs like ampicillin or estrogens. | Think of a recycling loop prolonging drug presence. |
| 7 | What is the significance of first-pass metabolism in GI drug pharmacokinetics? | First-pass metabolism occurs when a drug is extensively metabolized in the liver after absorption from the GI tract, reducing the bioavailability of certain oral drugs such as propranolol or lidocaine. | First-pass reduces the amount of active drug reaching systemic circulation. |
| 8 | How can the use of antibiotics influence the pharmacokinetics of gastrointestinal drugs like digoxin? | Antibiotics can alter gut flora responsible for metabolizing certain drugs (e.g., digoxin), potentially leading to increased serum levels and toxicity if flora reduction impairs drug metabolism. | Gut bacteria play a role in drug metabolism. |
| 9 | Explain the impact of gastric surgery (e.g., gastric bypass) on the pharmacokinetics of orally administered drugs. | Gastric surgery can reduce gastric volume and alter pH and transit time, impairing drug dissolution and absorption, which may decrease bioavailability of certain medications such as calcium or iron supplements. | Altered anatomy affects drug absorption pathways. |
| 10 | What role does gastric emptying rate play in the absorption of sustained-release GI medications? | Faster gastric emptying can reduce the residence time of sustained-release formulations in the stomach, potentially leading to early drug release and decreased efficacy; slower emptying may delay onset. | Timing of emptying impacts drug release. |
| 11 | Why should clinicians be cautious when prescribing medications that affect GI motility in patients on other oral drugs? | Drugs affecting GI motility (e.g., prokinetics or antispasmodics) can alter absorption by changing transit time, either enhancing or impairing the bioavailability of co-administered drugs. | Motility influences drug transit and absorption. |
| 12 | How does the presence of food in the stomach influence the pharmacokinetics of certain GI drugs? | Food can delay gastric emptying, alter gastric pH, and interact physically or chemically with drugs, affecting their dissolution, absorption rate, and overall bioavailability, as seen with drugs like ketoconazole or calcium carbonate. | Food effects can be beneficial or detrimental. |
| 13 | What is the significance of drug-drug interactions involving P-glycoprotein in the GI tract? | P-glycoprotein acts as an efflux transporter in the intestinal epithelium, limiting absorption of certain drugs (e.g., digoxin). Inhibition or induction of P-gp can increase or decrease drug bioavailability respectively. | P-gp controls drug efflux from intestinal cells. |
| 14 | Which pharmacokinetic parameter is most affected by changes in GI pH, and why? | Absorption is most affected because pH influences drug solubility and ionization, impacting how well the drug dissolves and is absorbed in the GI tract. | pH affects drug solubility. |
| 15 | Name a scenario where altered hepatic blood flow can impact GI drug pharmacokinetics. | In conditions like heart failure, reduced hepatic blood flow can decrease first-pass metabolism, leading to higher systemic drug levels of drugs like propranolol or lidocaine. | Blood flow influences first-pass effect. |
| 16 | What is a common clinical strategy to mitigate reduced absorption of a drug caused by co-administration with antacids? | Timing administration by spacing the drug and antacid (e.g., taking the drug 2 hours before or after the antacid) can reduce chelation and improve absorption. | Space out medications to prevent interactions. |
| 17 | Why is monitoring serum drug levels important when drugs are administered with agents affecting GI pH or motility? | Because alterations in GI environment or motility can unpredictably change absorption, leading to subtherapeutic or toxic drug levels, monitoring ensures safe and effective therapy. | Adjust therapy based on drug levels. |
| 18 | Describe how bile acid sequestrants affect the pharmacokinetics of fat-soluble vitamins and certain drugs. | Bile acid sequestrants bind bile acids, which can reduce the absorption of fat-soluble vitamins (A, D, E, K) and drugs that rely on bile salts for solubilization, leading to deficiencies or decreased drug efficacy. | Sequestrants interfere with fat-soluble absorption. |
| 19 | What is the impact of chronic diarrhea on the pharmacokinetics of orally administered drugs? | Chronic diarrhea can decrease drug absorption due to rapid transit and reduced contact time with the absorptive mucosa, potentially leading to lower plasma drug concentrations. | Diarrhea shortens absorption window. |
| 20 | How can the use of probiotics affect the pharmacokinetics of certain GI drugs? | Probiotics alter gut flora, which can impact drug metabolism, absorption, or enterohepatic recirculation, potentially modifying drug levels and effects. | Gut flora influence drug processing. |
Note: This preview shows only the first 20 cards. The complete deck contains 26 total cards. Start studying to access all flashcards.
Master all 26 flashcards
Explore other decks you might find helpful